Yasho Industries Limited has informed the Exchange about Investor Presentation
Date: May 02, 2025
To, BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai - 400 001.
Scrip Code: 541167
Dear Sir/ Madam,
Sub: Investor Presentation for Q4FY25
INDUSTRIES
To, National Stock Exchange of India Limited Exchange Plaza, Plot No. C/1, G Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400 051.
Symbol: YASHO
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Investor's Presentation for Q4FY25.
attached herewith the
please find
The said Investor’s Presentation will be simultaneously posted on the Company’s website at www.yashoindustries.com
We request you to kindly take the same on record.
Thanking You,
For Yasho Industries Limited
%7/" "
Parag Jhaveri Managing Director & CEO DIN: 01257685
Eucl: As above
YASHO INDUSTRIES LIMITED REGISTERED OFFICE: Office No. 101/102, Peninsula Heights, C.D Barfiwala Marg, Juhu lane, Andheri (West), Mumbai - 400058, India TEL: +91 22 62510100; FAX: +91 22 62510199; E-Mail: info@yashoindustries.com; CIN No: L74110MHI1985PLC037900
www.yashoindustries.com
INVESTOR PRESENTATION
XXX - 2025 Q4 and FY 2025
Safe Harbor
This presentation and the accompanying slides (the “Presentation”), which have been prepared by Yasho Industries Limited (the “Company”), have been prepared solely for
information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securities, and shall not form the basis or be relied on in
connection with any contract or binding commitment what so ever. No offering of securities of the Company will be made except by means of a statutory offering document
containing detailed information about the Company.
This Presentation has been prepared by the Company based on information and data which the Company considers reliable, but the Company makes no representation or
warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this Presentation.
This Presentation may not be all inclusive and may not contain all of the information that you may consider material. Any liability in respect of the contents of, or any omission
from, this Presentation is expressly excluded.
Certain matters discussed in this Presentation may contain statements regarding the Company’s market opportunity and business prospects that are individually and collectively
forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and
assumptions that are difficult to predict. These risks and uncertainties include, but are not limited to, the performance of the Indian economy and of the economies of various
international markets, the performance of the industry in India and world-wide, competition, the company’s ability to successfully implement its strategy, the Company’s future
levels of growth and expansion, technological implementation, changes and advancements, changes in revenue, income or cash flows, the Company’s market preferences and its
exposure to market risks, as well as other risks. The Company’s actual results, levels of activity, performance or achievements could differ materially and adversely from results
expressed in or implied by this Presentation. The Company assumes no obligation to update any forward-looking information contained in this Presentation. Any forward-looking
statements and projections made by third parties included in this Presentation are not adopted by the Company and the Company is not responsible for such third party
statements and projections.
2
COMPANY OVERVIEW
Business Overview
Leading specialty and performance chemicals manufacturer
Yasho Industries is a pioneer in specialty and fine chemicals manufacturing, incorporated in 1985 by Mr. Vinod Jhaveri. Equipped with a dedicated research and development centre and state-of the-art manufacturing facilities, we manufacture 142 products across five business verticals - Food Antioxidants, Aroma Chemicals, Rubber Chemicals, Lubricant Additives, and Specialty Chemicals. Our diverse product portfolio helps us serve a dynamic and far-reaching customer base across the world including the United States of America (USA), Europe, Asia, and the Middle East, securing around 65% of revenue from exports.
2
148
50+
2K+
32.5K
2
820+
Business Categories
Total product (All Developed in house)
Countries of presence
Customers
Manufacturing capacity (MT)
R & D centres
Employees (incl 30 R&D personnel)
4
Board of Directors
MR. VINOD JHAVERI
Chairman & Executive Director
MR. PARAG JHAVERI
Managing Director & CEO
MR. YAYESH JHAVERI
Whole Time Director
MR. ANURAG SURANA
MR. U R BHAT
Non-Executive Independent Director
Non-Executive Independent Director
DR. PRAKASH BHATE
Non-Executive Independent Director
MRS. SUDHA NAVANDAR Non-Executive Independent Director
5
Diversified portfolio of over 148 products
Consumer Division
Industrial Division
Applications
Applications
o Flavours and fragrances; personal care products - cosmetics &
toiletries
o Agro chemicals & Pharmaceutical products o Oral care preparations o Edible oil, Confectioneries & food stuff, Animal feed, Vitamin premix,
Nutraceutical
o Tyres, Automobile components, Conveyor belts, surgical gloves,
latex gloves, condoms, balloons
o Hydraulic, turbine, engine & gear oils, metal working fluids &
greases
o Stabilisers for acrylics, printing inks/coating, UPR resins and fibre
composite resins
Unlocking Global Opportunities with Our New State-of-the-Art Facility at Pakhajan
Strategic location
Optimized logistics and transportation connectivity
Technological Advancements
Leveraging cutting-edge technology for enhanced efficiency and productivity
Compliance and regulatory adherence
Built-in measures to ensure compliance with industry regulations and standards
Safety
Prioritizing employee and environmental safety with robust measures and protocols
Enhanced sustainability
Environmentally friendly practices and reduced carbon footprint
Improved quality control
Enhanced processes for superior product quality
Research & Development
Research & Development
Quality Control
As the cornerstone of our business, R&D is led by our promoters with active contribution and guidance
We are working on process improvements and new products which align with our business portfolio
Recently, we have upgraded our R&D facility and now have more than 30 chemists contributing actively
Several projects are in various stages of development, and we are confident that this will help us to achieve our future growth
Research & Development & Quality Control is our core strength. YIL continues to invest in R&D and to ensure sustainable operations throughout its facilities
technological upgradation
Our In-house testing facility & the state-of- the-art laboratory uses modern quality control methods and sophisticated instrumentation such as: •
AAS(Atomic Absorption Spectrophotometer) CHNS Analyzer Differential Scanning Calorimeter (DSC) FTIR (Fourier Transforms Infrared Spectrophotometer) GC (Gas Chromatography) HPLC (High-Performance Liquid Chromatography) UV Spectrophotometer
• • •
• •
•
Certifications & Accreditation
ISO Certification
FSSC 22000 Certification
FSSAI Certification
NSF Certified
STAR KOSHER Certification
FAMIQS Certification
ecovadis Certified
HALAL Certification
8
Q4 & FY25 Results Highlights
Management Commentary on Results – Q4 & FY25
Highlights of Q4FY25:
•
Revenue Volumes and Value has increased by 20% and 8% for Q4FY25 and 18% and 13% for FY25 respectively.
• Operating and EBITDA Margins continue to improve due to better product mix and improved efficiencies.
Outlook:
❖ Pakhajan facility operated with ~50% capacity utilization in March 2025 and we see this improving further to ~ 70% for FY26.
❖ We expect to increase our revenue by 40-50% in FY 26 based on increased capacity utilization of our Pakhajan facility.
❖ The Company’s US warehouse has become operational in March 2025. With this, the Company is in a better position to service the US market.
10
Results Highlights (Q4 & FY25)
Revenue
EBITDA
(Rs. In lacs)
PAT
5,794
60,097
67,725
10,721
11,829
1,794
17,233
18,553
3,145
3,559
503
611
Q4FY24
Q4FY25
FY24
FY25
Q4FY24 Q4FY25
FY24
FY25
Q4FY24 Q4FY25
FY24
FY25
Gross Margin %
EBITDA Margin %
PAT Margin %
43.1%
42.4%
36.9%
36.8%
19.2%
18.3%
17.8%
10.4%
9.6%
17.5%
2.7%
0.9%
Q4FY24 Q4FY25
FY24
FY25
Q4FY24
Q4FY25
FY24
FY25
Q4FY24
Q4FY25
FY24
FY25
11
Results Highlights (Q4 & FY25)
Category-wise Revenue Breakup
Geography-wise Revenue Breakup
Industrial Chemicals
Consumer Chemicals
International
Domestic
Q4FY25
Q4FY24
85%
84%
15%
16%
Q4FY25
Q4FY24
67%
66%
33%
34%
Category-wise Revenue Breakup
Geography-wise Revenue Breakup
Industrial Chemicals
Consumer Chemicals
International
Domestic
FY25
FY24
83%
84%
17%
16%
FY25
FY24
65%
63%
35%
37%
Consolidated Income Statement – Q4 & FY25
13
Yasho Industries LimitedPnL for Q4 FY25….>>>>Particulars Q4 FY25Q4 FY24Y-o-YQ3 FY25Q-o-QFY25FY24Revenue from Operations18,28117,2036.3%14,89116%66,85059,356Other Income2723064875741Total Revenue18,55317,23314,95567,72560,097Cost of Material Consumed10,6568,46111,92646,04334,406Change in Inventories of Finished goods & Work in Progress-1062,405-3,787-7,0373,605Total Material Consumed10,55010,8668,13939,00638,011Gross Profit8,0036,3676,81528,71922,086Gross Profit Margin (%)43.1%36.9%45.6%42.4%36.8%Employee Expenses 1,6811,1891,6256,4484,316Other Expenses 2,7622,0332,43910,4427,049EBITDA 3,5593,14513.2%2,75111,82910,721EBITDA Margin (%) 19.2%18.3%18.4%17.5%17.8%Depreciation 1298397130150061562EBIT2,2612,7491,4506,8229,159EBIT Margin (%)12.2%16.0%9.7%10.1%15.2%Finance Cost 1458447163859201487Profit before Tax8032,302-1879027,672Profit before Tax(%)4.3%13.4%-1.3%1.3%12.8%Tax 299508-1052901879Profit After Tax5031,794-826115,794PAT Margin (%) 2.7%10.4%-0.6%0.9%9.6%EPS -0.7715.74-0.777.8550.83Consolidated Balance Sheet
14
Assets (Rs in lacs)Mar’25Mar’24Equity & Liabilities (Rs in lacs)Mar’25Mar’24Property, plant and equipment 58,961 16,462 Equity Share Capital 1,206 1,140 Capital Work‐in‐Progress 145 46,119 Other Equity 40,764 28,331 Right of Use Asset 2,230 2,926 Total Equity 41,970 29,471 Investment - Financial liabilitiesOther Loan & Advances 21 16 1. Borrowing 32,445 33,365 Other Intangible Assets 1,186 885 2. Lease Liabilities 1,248 2,111 Other Investments - 3. Trade Payables - 5,173 Other Non Current Assets 1,976 2,613 Long term provisions 556 334 Deferred tax Liabilities (Net) 979 708 Total Non‐Current Assets 64,519 69,021 Total Non‐Current Liabilities 35,228 41,690 Financial AssetsFinancial Liabilities(i)Inventories 26,405 13,507 (ii) Borrowings 23,407 21,479 (ii) Trade Receivable 13,399 11,998 (ii) Lease Liabilities 1,156 949 (iii) Cash and Cash Equivalents 625 10 (iii) Trade Payables - Micro & Small 311 674 (iv) Bank balances other than above 2,218 1,179 (iv) Trade Payables - Others 6,183 4,121 (v) Other Loan & Advances 25 23 (iv) Other Financial Liabilities - 24 Current Tax Assets (Net) 286 232 Other Current Liabilities 256 282 Other Current Assets 1,939 3,299 Short Term Provisions 904 577 Total Current Assets 44,896 30,247 Total Current Liabilities 32,217 28,106 Total Assets 1,09,415 99,269 Total Equity & Liabilities 1,09,415 99,268 Consolidated Cashflow Statement
15
Cash Flow Statement (Rs. lacs.)Mar’25Mar’24Cash Flow from Operating ActivitiesProfit before Tax9037,672Adjustment for Non-Operating Items10,6602,920Operating Profit before Working Capital Changes11,56310,592Changes in Working Capital15,729555Cash Generated from Operations-4,16611,147Less: Direct Taxes paid312,128Net Cash from Operating Activities-4,1979,019Cash Flow from Investing Activities-876-30,412Cash Flow from Financing Activities5,92221,385Net increase/ (decrease) in Cash & Cash equivalent-235-34Add: Cash and cash equivalents as at 1st April615-42Add: Net effect of exchange gain on cash and cash equivalents1052Cash and cash equivalents as at end of the period 62510Financial Performance
Total Revenue
68,259
67,725
62,299
60,097
Gross Profit
26,738
23,376
22,086
28,719
36,952
13,586
FY21
FY22
FY23
FY24
FY25
FY21
FY22
FY23
FY24
FY25
EBITDA
PAT
12,602
10,330
10,721
11,829
5,909
6,787
5,728
5,229
2,148
611
FY21
FY22
FY23
FY24
FY25
FY21
FY22
FY23
FY24
FY25
16
Financial Performance
ROE (%)
ROCE (%)
Net Debt / Equity (x)
27.21
30.21
28.52
19.66
32.11
34.16
24.63
1.46
12.87
8.83
FY21
FY22
FY23
FY24
FY25
FY21
FY22
FY23
FY24
FY25
2.00
1.50
1.00
0.50
-
Fixed Asset Turnover (x)
Working Capital Days
4.94
4.40
3.77
3.65
1.77
210
122
122
91
108
FY21
FY22
FY23
FY24
FY25
FY21
FY22
FY23
FY24
FY25
2.00
1.90
1.30
1.33
1.00
FY21
FY22
FY23
FY24
FY25
Cash Flow from Operations
11,147
3,901
3,622
5,785
FY21
FY22
FY23
FY24
FY25
-4,166
17
Shareholders Information
Stock Information (as on 2nd May 2025)
Market Capitalization (₹)
Shares Outstanding
Free Float
Symbol BSE / NSE
Stock Performance Chart
(As on 31st March 2025)
Shareholding Pattern (%)
7.24%
0.46%
1,951.32
12.0 mn.
547.95
541167 / YASHO
24.29%
67.99%
Promoters
Public
FII
DII
Mr. Chirag Shah Chief Financial Officer
chirag@yashoindustries.com
www.yashoindustries.com
chirag@yashoindustries.com www.yashoindustries.com
CIN – L74110MH1985PLC037900
Investor Relations:
bhavya.shah@in.mpms.mufg.com
Mr. Bhavya Shah bhavya.shah@in.mpms.mufg.com +91 80827 48577
masoom.rateria@in.mpms.mufg.com
Ms. Masoom Rateria masoom.rateria@in.mpms.mufg.com +91 87189 91940
541167
YASHO
YASHO:IN
YASO:NS